News/ News/ News/ Oncology/ R&D AstraZeneca agrees $1.3bn deal to buy oncology player TeneoTwo Phil Taylor Amgen, AstraZeneca, Blincyto, Gilead Sciences, immuno-oncology, M&A, non-Hodgkin lymphoma, Oncology, Tecartus, TeneoTwo 0 Comment AstraZeneca has signed a deal to buy US biotech TeneoTwo in a deal worth up to $1.27 billion Share X AstraZeneca agrees $1.3bn deal to buy oncology player TeneoTwo https://pharmaphorum.com/news/astrazeneca-agrees-1-3bn-deal-to-buy-oncology-player-teneotwo/